HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

Gi‐Ae Kim, Young‐Suk Lim, Jihyun An, +7

Gut

Association between non-alcoholic fatty liver disease and cancer incidence rate

Gi‐Ae Kim, Han Chu Lee, Jaewon Choe, +9

Journal of Hepatology

ObesityMetabolic SyndromeCancer Incidence RateMetabolic Associated SteatohepatitisCancer Epidemiology +12

High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B

Gi‐Ae Kim, Young‐Suk Lim, Seungbong Han, +5

Gut

Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early‐Stage Hepatocellular Carcinoma

Jonggi Choi, Gi‐Ae Kim, Seungbong Han, +3

Hepatology

Evaluation of Early-Stage Hepatocellular Carcinoma by Magnetic Resonance Imaging With Gadoxetic Acid Detects Additional Lesions and Increases Overall Survival

Hyung-Don Kim, Young‐Suk Lim, Seungbong Han, +6

Gastroenterology

High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation

Gwang Hyeon Choi, Gi‐Ae Kim, Jonggi Choi, +2

Alimentary Pharmacology & Therapeutics

Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients

Gi‐Ae Kim, Seungbong Han, Gwang Hyeon Choi, +2

Alimentary Pharmacology & Therapeutics

Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis

Gi‐Ae Kim, Ju Hyun Shim, Sang Min Yoon, +11

Journal of Vascular and Interventional Radiology

Surgical OncologyHepatologyRadiation TherapyMedicinePropensity Score Analysis +8

Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study

Min Jung Lee, Eun‐Hee Kim, Sung-Jin Bae, +6

Gut and Liver

Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B

Hye‐Lin Kim, Gi‐Ae Kim, Jae‐A Park, +3

Gut